198 related articles for article (PubMed ID: 17905518)
1. Novel cytotoxic drugs: old challenges, new solutions.
Ismael GF; Rosa DD; Mano MS; Awada A
Cancer Treat Rev; 2008 Feb; 34(1):81-91. PubMed ID: 17905518
[TBL] [Abstract][Full Text] [Related]
2. Current perspectives of epothilones in breast cancer.
Cardoso F; de Azambuja E; Lago LD
Eur J Cancer; 2008 Feb; 44(3):341-52. PubMed ID: 18178426
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of ixabepilone (BMS-247550), a novel epothilone B analogue].
Villanueva C; Dufresne A; Pivot X; Viel E
Bull Cancer; 2008 Feb; 95(2):197-204. PubMed ID: 18304905
[TBL] [Abstract][Full Text] [Related]
4. The epothilones: how pharmacology relates to clinical utility.
Michaud LB
Ann Pharmacother; 2009 Jul; 43(7):1294-309. PubMed ID: 19584389
[TBL] [Abstract][Full Text] [Related]
5. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G
Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
[TBL] [Abstract][Full Text] [Related]
6. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
Ojima I
Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
[TBL] [Abstract][Full Text] [Related]
7. Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer.
Steinberg M
Clin Ther; 2008 Sep; 30(9):1590-617. PubMed ID: 18840366
[TBL] [Abstract][Full Text] [Related]
8. Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors.
Rivera E; Lee J; Davies A
Oncologist; 2008 Dec; 13(12):1207-23. PubMed ID: 19088324
[TBL] [Abstract][Full Text] [Related]
9. The epothilones: translating from the laboratory to the clinic.
Lee JJ; Swain SM
Clin Cancer Res; 2008 Mar; 14(6):1618-24. PubMed ID: 18347162
[TBL] [Abstract][Full Text] [Related]
10. Novel agents that target tublin and related elements.
Rowinsky EK; Calvo E
Semin Oncol; 2006 Aug; 33(4):421-35. PubMed ID: 16890797
[TBL] [Abstract][Full Text] [Related]
11. Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer.
Morris PG; Fornier MN
Clin Adv Hematol Oncol; 2009 Feb; 7(2):115-22. PubMed ID: 19367253
[TBL] [Abstract][Full Text] [Related]
12. [Development of new antineoplastic agents: 10 years of active clinical research marked by the evolution of treatment, from an empirical to a rational approach].
Awada A
Bull Mem Acad R Med Belg; 2001; 156(6 Pt 2):338-47. PubMed ID: 11928224
[TBL] [Abstract][Full Text] [Related]
13. Ixabepilone and the narrow path to developing new cytotoxic drugs.
Gianni L
J Clin Oncol; 2007 Aug; 25(23):3389-91. PubMed ID: 17606970
[No Abstract] [Full Text] [Related]
14. Insulin, chemotherapy, and the mechanisms of malignancy: the design and the demise of cancer.
Ayre SG; Garcia y Bellon DP; Garcia DP
Med Hypotheses; 2000 Oct; 55(4):330-4. PubMed ID: 11000062
[TBL] [Abstract][Full Text] [Related]
15. Overcoming drug resistance in patients with metastatic breast cancer.
Wong ST; Goodin S
Pharmacotherapy; 2009 Aug; 29(8):954-65. PubMed ID: 19637949
[TBL] [Abstract][Full Text] [Related]
16. Promising novel cytotoxic agents and combinations in metastatic prostate cancer.
Bradley DA; Hussain M
Cancer J; 2008; 14(1):15-9. PubMed ID: 18303478
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
18. [New basis for development of anticancer drugs].
Danø K
Ugeskr Laeger; 2001 Jul; 163(27):3759-62. PubMed ID: 11466981
[TBL] [Abstract][Full Text] [Related]
19. Ligand-based targeted therapy for cancer tissue.
Das M; Mohanty C; Sahoo SK
Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
[TBL] [Abstract][Full Text] [Related]
20. Advances in chemotherapy options for metastatic breast cancer: introduction of epothilones.
McGee L
ONS Connect; 2007; 22(8 Suppl):29-30. PubMed ID: 17824553
[No Abstract] [Full Text] [Related]
[Next] [New Search]
